Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II study

Ribrag, VincentKim, Won SeogBouabdallah, RedaLim, Soon ThyeCoiffier, BertrandIllés, ÁrpádLemieux, BernardDyer, Martin J. S.Offner, FritzFelloussi, ZakiaKloos, IoanaLuan, YingVezan, RemusGraef, ThorstenMorschhauser, Franck2017-08-022017-08-022017Haematologica. -102 : 5 (2017), p. 903-909. -Haematologica. - 0390-60780390-6078http://hdl.handle.net/2437/242837Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II studyfolyóiratcikkopen access journalhttp://webpac.lib.unideb.hu:8082/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM070025OrvostudományokKlinikai orvostudományokFerrata Storti Foundationhttp://dx.doi.org/10.3324/haematol.2016.154377http://www.haematologica.org/content/102/5/9032018-05-1800040249090002785018941534